Bermuda Virtual Tech Summit 2021 Kicks Off Tomorrow
The Bermuda Business Development Agency (BDA) encourages the public to register now for its Bermuda Virtual Tech Summit 2021 beginning tomorrow, Wednesday, October 13.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211012005845/en/
BDA CEO David Hart (Photo: Business Wire)
This year’s summit – centered around the theme Transforming the Digital Landscape – offers an exciting schedule of thought-provoking panels featuring global tech leaders.
David Hart, BDA CEO said, “On behalf of the BDA, we are proud to offer this three-day event featuring 79 speakers across 23 panels. Sixty-three local and international companies are participating, along with 12 BDA sponsors and partners who are helping the event to take place. Engaging, cutting-edge tech topics such as: decentralised finance, non-fungible tokens, digital identity and the transformation of value exchange will be discussed, as well as how Bermuda can be the innovative platform for your tech business.”
The final agenda is available via the BDA website – a selection of highlighted panels includes:
- “The Transformation of Value Exchange” featuring Sheila Warren, Deputy Head, Centre for the Fourth Industrial Revolution Network; Executive Committee, World Economic Forum; Dante Disparte, Chief Strategy Officer and Head of Global Policy, Circle; Moad Fahmi, Senior Advisor, FinTech, Bermuda Monetary Authority; Eric Kryski, Co-Founder, Bidali; and Joseph Seibert, Group Managing Director/Senior VP, Digital Asset Banking, Signature Bank
- “Risk vs. Reward — The Potential Transformative Power of Decentralised Finance” featuring Natalie Neto, Partner, Walkers; Philippe Bekhazi, Founder and CEO, XBTO Group and StableHouse; Jordan Momtazi, Core Contributor (ex-COO), Synthetix; Denis Pitcher, CEO/Chief Architect, resPartner Ltd., Independent Non-Executive Director, Bittrex Global, and Fintech Strategic Advisor to the Premier and Office of FinTech, Government of Bermuda; and Ajit Tripathi, Head of Institutional Business, Aave
- “Cutting-Edge Innovation in Bermuda” featuring Vanessa Williams, Chief Compliance Officer, CrossTower; Sandra DeSilva, CEO & Chief Architect, Nova; Nina Kilbride, Founder, Mothership; and Simone Smith-Bean, Member, BDA FinTech Legal & Regulatory Committee, Managing Director, Smith Bean & Co.
- “Digital Identity — Fundamental to the Transformation of Financial Services” featuring Stan Stalnaker, Chair, Bermuda Global Fintech Advisory Board; Founding Director and Chief Strategy Officer for Hub Culture/Ven/Ultra/AQUA Travel; Alex McD White, Privacy Commissioner, Office of the Privacy Commissioner for Bermuda; Justin Newton, CEO, Netki, Inc.; Bruce Silcoff, CEO & Co-Founder, Shyft; and Lucy Yang, Community Director, Covid Credentials Initiative
- “Non-Fungible Tokens (NFT) — Hyped-Up Fad or Revolutionary Shift?” featuring Michael Casey, Chief Content Officer, CoinDesk. Panelists include Kevin Abosch, NFT & Crypto Artist; Lucia Gallardo, Founder & CEO, Emerge; and Vinay Gupta, Founder & CEO, Mattereum, and Author of The Future of Stuff.
Mr. Hart said, “Aggregating this calibre of participants is possible due to our hard-working BDA staff and the support of our sponsors and partners, who the BDA graciously thanks for their engagement. This includes Appleby, Bespoke Analytics, Bittrex Global, Circle, and Walkers as platinum sponsors; 24 Exchange as gold sponsors; Carey Olsen, StableHouse, Westham Trade Company and XBTO as silver sponsors, Global Blockchain Business Council as content partner and Goslings as spirits partner.”
CONNECTING BUSINESS
The BDA encourages direct investment and helps companies start up, relocate, or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211012005845/en/
Contact information
Stuart Roberts, Director of Communications & PR
stuart@bda.bm, +1 441 292 7774
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin
IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 13:30:00 CEST | Press release
IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde